- Home
- AIZ vs EXEL Comparison
AIZ vs EXEL Comparison
Compare AIZ & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIZ
- EXEL
- Stock Information
- Founded
- AIZ 1892
- EXEL 1994
- Country
- AIZ United States
- EXEL United States
- Employees
- AIZ N/A
- EXEL N/A
- Industry
- AIZ Property-Casualty Insurers
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIZ Finance
- EXEL Health Care
- Exchange
- AIZ Nasdaq
- EXEL Nasdaq
- Market Cap
- AIZ 10.1B
- EXEL 11.3B
- IPO Year
- AIZ N/A
- EXEL 2000
- Fundamental
- Price
- AIZ $196.84
- EXEL $44.08
- Analyst Decision
- AIZ Strong Buy
- EXEL Buy
- Analyst Count
- AIZ 6
- EXEL 18
- Target Price
- AIZ $231.33
- EXEL $43.00
- AVG Volume (30 Days)
- AIZ 419.5K
- EXEL 3.3M
- Earning Date
- AIZ 08-05-2025
- EXEL 08-05-2025
- Dividend Yield
- AIZ 1.62%
- EXEL N/A
- EPS Growth
- AIZ N/A
- EXEL 237.58
- EPS
- AIZ 12.82
- EXEL 2.20
- Revenue
- AIZ $12,071,400,000.00
- EXEL $2,298,922,000.00
- Revenue This Year
- AIZ $6.89
- EXEL $9.37
- Revenue Next Year
- AIZ $4.49
- EXEL $11.05
- P/E Ratio
- AIZ $15.42
- EXEL $19.98
- Revenue Growth
- AIZ 6.18
- EXEL 24.49
- 52 Week Low
- AIZ $160.12
- EXEL $21.82
- 52 Week High
- AIZ $230.55
- EXEL $49.62
- Technical
- Relative Strength Index (RSI)
- AIZ 47.82
- EXEL 57.96
- Support Level
- AIZ $193.94
- EXEL $42.66
- Resistance Level
- AIZ $200.18
- EXEL $49.62
- Average True Range (ATR)
- AIZ 3.70
- EXEL 1.58
- MACD
- AIZ -0.40
- EXEL 0.10
- Stochastic Oscillator
- AIZ 31.12
- EXEL 43.24
About AIZ Assurant Inc.
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions (including extended service contracts, insurance policies and related services), extended service contracts and related services for consumer electronics and appliances, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. Key revenue is generated from Global Lifestyle segment.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.